Rad51 Inhibition is an Effective Means of Targeting DNA Repair in Glioma Models and CD133+ Tumor-derived Cells

Overview

Journal Neuro Oncol

Publisher Oxford University Press

Specialties Neurology
Oncology

Date 2011 Mar 3

PMID 21363882

Citations 50

Authors

Susan C Short

Silvia Giampieri

Mulugeta Worku

Marisa Alcaide-German

George Sioftanos

Sara Bourne

Ka Ian Lio

Maya Shaked-Rabi

Christine Martindale

Affiliations

Soon will be listed here.

Abstract

High grade gliomas (HGGs) are characterized by resistance to radiotherapy and chemotherapy. Targeting Rad51-dependent homologous recombination repair may be an effective target for chemo- and radiosensitization. In this study we assessed the role of Rad51-dependent repair on sensitivity to radiation and temozolomide (TMZ) as single agents or in combination. Repair protein levels in established glioma cell lines, early passage glioblastoma multiforme (GBM) cell lines, and normal human astrocytes (NHAs) were measured using western blot. Viability and clonogenic survival assays were used to measure the effects of Rad51 knockdown with radiation (XR) and TMZ. Immunocytochemistry was used to evaluate kinetics of Rad51 and γ-H2AX repair foci. Immunohistochemistry was used to assess Rad51 protein levels in glioma specimens. Repair proteins including Rad51 are upregulated in HGG cells compared with NHA. Established glioma cell lines show a dose-dependent increase in Rad51 foci formation after XR and TMZ. Rad51 levels are inversely correlated with radiosensitivity, and downregulation markedly increases the cytotoxicity of TMZ. Rad51 knockdown also promotes more residual γ-H2AX foci 24 h after combined treatment. Newly established GBM cell lines also have high Rad51 levels and are extremely sensitive to Rad51 knockdown. Clinical samples from recently resected gliomas of varying grades demonstrate that Rad51 levels do not correlate with tumor grade. Rad51-dependent repair makes a significant contribution to DNA repair in glioma cells and contributes to resistance to both XR and TMZ. Agents targeting Rad51-dependent repair would be effective adjuvants in standard combination regimens.

Citing Articles

PRMT5 inhibition sensitizes glioblastoma tumor models to temozolomide.

Onishi S, Jayamohan S, Chowdhury A, Rivas S, Otani Y, Murphy S Res Sq. 2025; .

PMID: 39989968 PMC: 11844640. DOI: 10.21203/rs.3.rs-5936706/v1.

Overexpression of miR-124 enhances the therapeutic benefit of TMZ treatment in the orthotopic GBM mice model by inhibition of DNA damage repair.

Wei Y, Wang P, Zhao J, Fan X, Jiang J, Mu X Cell Death Dis. 2025; 16(1):47.

PMID: 39865088 PMC: 11770086. DOI: 10.1038/s41419-025-07363-z.

CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive/HER2-negative breast cancer.

Sato T, Oshi M, Huang J, Chida K, Roy A, Endo I Breast Cancer Res Treat. 2024; 208(2):415-427.

PMID: 39017815 PMC: 11849687. DOI: 10.1007/s10549-024-07434-3.

MGMT function determines the differential response of ATR inhibitors with DNA-damaging agents in glioma stem cells for GBM therapy.

Leong V, Khan S, Sharma P, Wu S, Thomas R, Li X Neurooncol Adv. 2024; 6(1):vdad165.

PMID: 38213834 PMC: 10783493. DOI: 10.1093/noajnl/vdad165.

The therapeutic targets of N6-methyladenosine (m6A) modifications on tumor radioresistance.

Zhang Y, Gu W, Shao Y Discov Oncol. 2023; 14(1):141.

PMID: 37522921 PMC: 10390431. DOI: 10.1007/s12672-023-00759-3.

References

Esashi F, Christ N, Gannon J, Liu Y, Hunt T, Jasin M . CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair. Nature. 2005; 434(7033):598-604. DOI: 10.1038/nature03404. View

Daido S, Yamamoto A, Fujiwara K, Sawaya R, Kondo S, Kondo Y . Inhibition of the DNA-dependent protein kinase catalytic subunit radiosensitizes malignant glioma cells by inducing autophagy. Cancer Res. 2005; 65(10):4368-75. DOI: 10.1158/0008-5472.CAN-04-4202. View

van Rijn J, Heimans J, van den Berg J, van der Valk P, Slotman B . Survival of human glioma cells treated with various combination of temozolomide and X-rays. Int J Radiat Oncol Biol Phys. 2000; 47(3):779-84. DOI: 10.1016/s0360-3016(99)00539-8. View

Short S, Mitchell S, Boulton P, Woodcock M, Joiner M . The response of human glioma cell lines to low-dose radiation exposure. Int J Radiat Biol. 1999; 75(11):1341-8. DOI: 10.1080/095530099139214. View

Tisdale M . Antitumor imidazotetrazines--XV. Role of guanine O6 alkylation in the mechanism of cytotoxicity of imidazotetrazinones. Biochem Pharmacol. 1987; 36(4):457-62. DOI: 10.1016/0006-2952(87)90351-0. View

Douglas J, Stelzer K, Mankoff D, Tralins K, Krohn K, Muzi M . [F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: clinical outcomes and patterns of failure. Int J Radiat Oncol Biol Phys. 2005; 64(3):886-91. DOI: 10.1016/j.ijrobp.2005.08.013. View

Graeser M, McCarthy A, Lord C, Savage K, Hills M, Salter J . A marker of homologous recombination predicts pathologic complete response to neoadjuvant chemotherapy in primary breast cancer. Clin Cancer Res. 2010; 16(24):6159-68. PMC: 3432445. DOI: 10.1158/1078-0432.CCR-10-1027. View

Cahill D, Levine K, Betensky R, Codd P, Romany C, Reavie L . Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment. Clin Cancer Res. 2007; 13(7):2038-45. PMC: 2873832. DOI: 10.1158/1078-0432.CCR-06-2149. View

Short S, Martindale C, Bourne S, Brand G, Woodcock M, Johnston P . DNA repair after irradiation in glioma cells and normal human astrocytes. Neuro Oncol. 2007; 9(4):404-11. PMC: 1994097. DOI: 10.1215/15228517-2007-030. View

10.

Golding S, Rosenberg E, Khalil A, McEwen A, Holmes M, Neill S . Double strand break repair by homologous recombination is regulated by cell cycle-independent signaling via ATM in human glioma cells. J Biol Chem. 2004; 279(15):15402-10. DOI: 10.1074/jbc.M314191200. View

11.

Quiros S, Roos W, Kaina B . Processing of O6-methylguanine into DNA double-strand breaks requires two rounds of replication whereas apoptosis is also induced in subsequent cell cycles. Cell Cycle. 2009; 9(1):168-78. DOI: 10.4161/cc.9.1.10363. View

12.

Yamamoto A, Taki T, Yagi H, HABU T, Yoshida K, Yoshimura Y . Cell cycle-dependent expression of the mouse Rad51 gene in proliferating cells. Mol Gen Genet. 1996; 251(1):1-12. DOI: 10.1007/BF02174338. View

13.

Chalmers A, Ruff E, Martindale C, Lovegrove N, Short S . Cytotoxic effects of temozolomide and radiation are additive- and schedule-dependent. Int J Radiat Oncol Biol Phys. 2009; 75(5):1511-9. DOI: 10.1016/j.ijrobp.2009.07.1703. View

14.

Desjardins A, Quinn J, Vredenburgh J, Sathornsumetee S, Friedman A, Herndon J . Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas. J Neurooncol. 2007; 83(1):53-60. DOI: 10.1007/s11060-006-9302-2. View

15.

Roos W, Nikolova T, Quiros S, Naumann S, Kiedron O, Zdzienicka M . Brca2/Xrcc2 dependent HR, but not NHEJ, is required for protection against O(6)-methylguanine triggered apoptosis, DSBs and chromosomal aberrations by a process leading to SCEs. DNA Repair (Amst). 2008; 8(1):72-86. DOI: 10.1016/j.dnarep.2008.09.003. View

16.

Hegi M, Diserens A, Gorlia T, Hamou M, De Tribolet N, Weller M . MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005; 352(10):997-1003. DOI: 10.1056/NEJMoa043331. View

17.

Nomme J, Takizawa Y, Martinez S, Renodon-Corniere A, Fleury F, Weigel P . Inhibition of filament formation of human Rad51 protein by a small peptide derived from the BRC-motif of the BRCA2 protein. Genes Cells. 2008; 13(5):471-81. DOI: 10.1111/j.1365-2443.2008.01180.x. View

18.

Wedge S, Porteous J, Glaser M, Marcus K, Newlands E . In vitro evaluation of temozolomide combined with X-irradiation. Anticancer Drugs. 1997; 8(1):92-7. DOI: 10.1097/00001813-199701000-00013. View

19.

Hashimoto Y, Ray Chaudhuri A, Lopes M, Costanzo V . Rad51 protects nascent DNA from Mre11-dependent degradation and promotes continuous DNA synthesis. Nat Struct Mol Biol. 2010; 17(11):1305-11. PMC: 4306207. DOI: 10.1038/nsmb.1927. View

20.

Saydam O, Saydam N, Glauser D, Pruschy M, Dinh-Van V, Hilbe M . HSV-1 amplicon-mediated post-transcriptional inhibition of Rad51 sensitizes human glioma cells to ionizing radiation. Gene Ther. 2007; 14(15):1143-51. DOI: 10.1038/sj.gt.3302967. View